drugset / Trial / NCT04764825

Methadone for Spinal Fusion Surgery.

NCT04764825

RandomizedParallel-groupQuadruple-blindTreatment

Summary

A prospective double-blind, randomized controlled trial investigating the effect of a single-dose of intraoperative methadone in patients undergoing spinal fusion.

Timeline

Start
2021-02-26
Primary completion
2024-03-19
Completion
2024-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Methadone Other / unclassified 0.15 mg/kg Intravenous
Subject Methadone Other / unclassified 0.2 mg/kg Intravenous
Comparator Morphine Other / unclassified 0.15 mg/kg Intravenous
Comparator Morphine Other / unclassified 0.2 mg/kg Intravenous